Nektar Therapeutics | Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Agios Pharmaceuticals USD 1.28B 85.22M 2025-09
ALKERMES USD 1.73B 108.85M 2025-09
Alterity Therapeutics Limited AUD 22.81M 5.29M 2023-06
Amgen USD 9.62B 2.19B 2025-09
Baxter International USD 7.24B 79M 2025-09
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
Biogen USD 18.21B 573.5M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Cara Therapeutics USD 32.93M 41M 2025-06
Cipla INR 329.19B 16.3B 2025-09
Dr.Reddys Laboratories INR 375.76B 13.67B 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 23.79B 5.52B 2025-09
Esperion Therapeutics USD -451.36M 17.85M 2025-09
Exelixis USD 2.16B 127.16M 2025-09
Gilead Sciences USD 21.46B 1.78B 2025-09
GlaxoSmithKline GBP 16.38B 229M 2025-12
Grifols EUR 6.08B 34.72M 2025-09
Halozyme Therapeutics USD 503.92M 171.17M 2025-09
Incyte USD 5.17B 516.28M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
MacroGenics USD 67M 20.38M 2025-09
Merck USD 51.85B 2.79B 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 3B 309.3M 2025-09
Novartis USD 44.75B 2.7B 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
Takeda JPY 7.64T 513.39B 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
Xencor USD 625.32M 4.96M 2025-09


Nektar Therapeutics Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.